Publications
Expression of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to antiandrogen therapy
Werner, CK,
Nna, UJ,
Sun, H,
Wilder-Romans, K,
Dresser, J,
Kothari, AU,
Zhou, W,
Yao, Y,
Rao, A,
Stallard, S,
Koschmann, C,
Bor, T,
Debinski, W,
Hegedus, AM,
Morgan, MA,
Venneti, S,
Baskin-Bey, E,
Spratt, DE,
Colman, H,
Sarkaria, JN,
Chinnaiyan, AM,
Eisner, JR,
Speers, C,
Lawrence, TS,
Strowd, RE,
Wahl, DR,
Mol Cancer Ther, 2020 Oct; DOI:10.1158/1535-7163.MCT-20-0095 Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
Algazi, AP,
Othus, M,
Daud, AI,
Lo, RS,
Mehnert, JM,
Truong, T-G,
Conry, R,
Kendra, K,
Doolittle, GC,
Clark, JI,
Messino, MJ,
Moore, DF,
Lao, C,
Faller, BA,
Govindarajan, R,
Harker-Murray, A,
Dreisbach, L,
Moon, J,
Grossmann, KF,
Ribas, A,
Nat Med, 2020 Oct; DOI:10.1038/s41591-020-1060-8 Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma.
Ravi, P,
Mantia, C,
Su, C,
Sorenson, K,
Elhag, D,
Rathi, N,
Bakouny, Z,
Agarwal, N,
Zakharia, Y,
Costello, BA,
McKay, RR,
Narayan, V,
Alva, A,
McGregor, BA,
Gao, X,
McDermott, DF,
Choueiri, TK,
JAMA Oncol, 2020 Oct; DOI:10.1001/jamaoncol.2020.2169 Characteristics of Head and Neck Squamous Cell Carcinoma Cell Lines Reflect Human Tumor Biology Independent of Primary Etiologies and HPV Status
Nair, TS,
Thomas, TB,
Yang, L,
Kakaraparthi, BN,
Morris, AC,
Clark, AM,
Campredon, LP,
Brouwer, AF,
Eisenberg, MC,
Meza, R,
Carey, TE,
Transl Oncol, 2020 Oct; DOI:10.1016/j.tranon.2020.100808 p120 catenin recruits HPV to γ-secretase to promote virus infection
Harwood, MC,
Dupzyk, AJ,
Inoue, T,
DiMaio, D,
Tsai, B,
PLoS Pathog, 2020 Oct; DOI:10.1371/journal.ppat.1008946 A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
Smith, DC,
Kroiss, M,
Kebebew, E,
Habra, MA,
Chugh, R,
Schneider, BJ,
Fassnacht, M,
Jafarinasabian, P,
Ijzerman, MM,
Lin, VH,
Mohideen, P,
Naing, A,
Invest New Drugs, 2020 Oct; DOI:10.1007/s10637-020-00899-1 Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers
Martinez Chanza, N,
Werner, L,
Plimack, E,
Yu, EY,
Alva, AS,
Crabb, SJ,
Powles, T,
Rosenberg, JE,
Baniel, J,
Vaishampayan, UN,
Berthold, DR,
Ladoire, S,
Hussain, SA,
Milowsky, MI,
Agarwal, N,
Necchi, A,
Pal, SK,
Sternberg, CN,
Bellmunt, J,
Galsky, MD,
Harshman, LC,
RISC Investigators, Array,
Eur Urol Oncol, 2020 Oct; DOI:10.1016/j.euo.2018.12.013 Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group
Baechle, JJ,
Marincola Smith, P,
Tan, M,
Solórzano, CC,
Lopez-Aguiar, AG,
Dillhoff, M,
Beal, EW,
Poultsides, G,
Makris, E,
Rocha, FG,
Crown, A,
Cho, C,
Beems, M,
Winslow, ER,
Rendell, VR,
Krasnick, BA,
Fields, R,
Maithel, SK,
Bailey, CE,
Idrees, K,
Ann Surg Oncol, 2020 Oct; DOI:10.1245/s10434-020-08497-4 PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and activation of immunoregulatory pathways
Maurer, L,
Venier, R,
Mukherjee, E,
Julian, C,
Daley, J,
Bailey, N,
Jacobs, M,
Kumar-Sinha, C,
Raphel, H,
Weiss, K,
Janeway, K,
Mody, R,
Lucas, P,
McAllister-Lucas, L,
Bailey, K,
2020 Sep; DOI:10.1101/2020.09.18.304238 Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial
Motzer, RJ,
Escudier, B,
George, S,
Hammers, HJ,
Srinivas, S,
Tykodi, SS,
Sosman, JA,
Plimack, ER,
Procopio, G,
McDermott, DF,
Castellano, D,
Choueiri, TK,
Donskov, F,
Gurney, H,
Oudard, S,
Richardet, M,
Peltola, K,
Alva, AS,
Carducci, M,
Wagstaff, J,
Chevreau, C,
Fukasawa, S,
Tomita, Y,
Gauler, TC,
Kollmannsberger, CK,
Schutz, FA,
Larkin, J,
Cella, D,
McHenry, MB,
Saggi, SS,
Tannir, NM,
Cancer, 2020 Sep; DOI:10.1002/cncr.33033 The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development
Palanisamy, N,
Yang, J,
Shepherd, PDA,
Li-Ning-Tapia, EM,
Labanca, E,
Manyam, GC,
Ravoori, MK,
Kundra, V,
Araujo, JC,
Efstathiou, E,
Pisters, LL,
Wan, X,
Wang, X,
Vazquez, ES,
Aparicio, AM,
Carskadon, SL,
Tomlins, SA,
Kunju, LP,
Chinnaiyan, AM,
Broom, BM,
Logothetis, CJ,
Troncoso, P,
Navone, NM,
Clin Cancer Res, 2020 Sep; DOI:10.1158/1078-0432.CCR-20-0479 Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis
Gottschlich, A,
Rivera-Andrade, A,
Bevilacqua, K,
Murchland, AR,
Isak, E,
Alvarez, CS,
Ogilvie, G,
Carey, TE,
Prince, M,
Dean, M,
Mendoza-Montano, C,
Meza, R,
BMC Public Health, 2020 Sep; DOI:10.1186/s12889-020-09478-8 Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas
Chung, C,
Sweha, SR,
Pratt, D,
Tamrazi, B,
Panwalkar, P,
Banda, A,
Bayliss, J,
Hawes, D,
Yang, F,
Lee, H-J,
Shan, M,
Cieslik, M,
Qin, T,
Werner, CK,
Wahl, DR,
Lyssiotis, CA,
Bian, Z,
Shotwell, JB,
Yadav, VN,
Koschmann, C,
Chinnaiyan, AM,
Blüml, S,
Judkins, AR,
Venneti, S,
Cancer Cell, 2020 Sep; DOI:10.1016/j.ccell.2020.07.008 Prognostic Value of the Intratumoral Lymphocyte to Monocyte Ratio and M0 Macrophage Enrichment in the Melanoma Immune Microenvironment
Jairath, N,
Farha, M,
Jairath, R,
Harms, P,
Tsoi, L,
Tejasvi, T,
2020 Sep; DOI:10.20944/preprints202009.0239.v1 Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
Koschmann, C,
Kawakibi, AR,
Tarapore, R,
Gardner, S,
Thomas, C,
Cartaxo, R,
Yadav, V,
Chi, A,
Kurz, S,
Wen, P,
Arrillaga, I,
Batchelor, T,
Butowski, N,
Sumrall, A,
Shonka, N,
Harrison, R,
Groot, JD,
Mehta, M,
Odia, Y,
Hall, M,
Daghistani, D,
Cloughesy, T,
Ellingson, B,
Kim, M,
Umemura, Y,
Garton, H,
Franson, A,
Robertson, P,
Schwartz, J,
Marini, B,
Pai, M,
Phoenix, T,
Ji, S,
Cantor, E,
Miklja, Z,
Mullan, B,
Bruzek, A,
Siada, R,
Cummings, J,
Stallard, S,
Wierzbicki, K,
Paul, A,
Wolfe, I,
Dun, M,
Cain, J,
Jiang, L,
Filbin, M,
Vats, P,
Kumar-Sinha, C,
Mody, R,
Chinnaiyan, A,
Pratt, D,
Venneti, S,
Lu, G,
Mueller, S,
Resnick, A,
Nazarian, J,
Waszak, S,
Allen, J,
2020 Sep; DOI:10.21203/rs.3.rs-69706/v1 Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy
Becerra, MF,
Venkatramani, V,
Reis, IM,
Soodana-Prakash, N,
Punnen, S,
Gonzalgo, ML,
Raolji, S,
Castle, EP,
Woods, ME,
Svatek, RS,
Weizer, AZ,
Konety, BR,
Tollefson, M,
Krupski, TL,
Smith, ND,
Shabsigh, A,
Barocas, DA,
Quek, ML,
Dash, A,
Parekh, DJ,
J Urol, 2020 Sep; DOI:10.1097/JU.0000000000001029 Co-clinical imaging resource program (CIRP): Bridging the translational divide to advance precision medicine
Shoghi, KI,
Badea, CT,
Blocker, SJ,
Chenevert, TL,
Laforest, R,
Lewis, MT,
Luker, GD,
Manning, HC,
Marcus, DS,
Mowery, YM,
Pickup, S,
Richmond, A,
Ross, BD,
Vilgelm, AE,
Yankeelov, TE,
Zhou, R,
Tomography, 2020 Sep; DOI:10.18383/j.tom.2020.00023 A Pilot Study of Atezolizumab Plus Hypofractionated Image Guided Radiation Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Qin, A,
Rengan, R,
Lee, S,
Santana-Davila, R,
Goulart, BHL,
Martins, R,
Baik, C,
Kalemkerian, GP,
Hassan, KA,
Schneider, BJ,
Hayman, JA,
Jolly, S,
Hearn, J,
Lawrence, TS,
Towlerton, AMH,
Tewari, M,
Thomas, D,
Zhao, L,
Brown, N,
Frankel, TL,
Warren, EH,
Ramnath, N,
Int J Radiat Oncol Biol Phys, 2020 Sep; DOI:10.1016/j.ijrobp.2019.10.047 Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy
Dong, D-H,
Zhang, X-F,
Lopez-Aguiar, AG,
Poultsides, G,
Rocha, F,
Weber, S,
Fields, R,
Idrees, K,
Cho, C,
Spolverato, G,
Maithel, SK,
Pawlik, TM,
J Surg Oncol, 2020 Sep; DOI:10.1002/jso.25978 Devices and techniques for endoscopic treatment of residual and fibrotic colorectal polyps (with videos)
Trindade, AJ,
Kumta, NA,
Bhutani, MS,
Chandrasekhara, V,
Jirapinyo, P,
Krishnan, K,
Melson, J,
Pannala, R,
Parsi, MA,
Schulman, AR,
Trikudanathan, G,
Watson, RR,
Maple, JT,
Lichtenstein, DR,
Gastrointest Endosc, 2020 Sep; DOI:10.1016/j.gie.2020.03.018 Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
Bian, Y,
Li, W,
Kremer, DM,
Sajjakulnukit, P,
Li, S,
Crespo, J,
Nwosu, ZC,
Zhang, L,
Czerwonka, A,
Pawłowska, A,
Xia, H,
Li, J,
Liao, P,
Yu, J,
Vatan, L,
Szeliga, W,
Wei, S,
Grove, S,
Liu, JR,
McLean, K,
Cieslik, M,
Chinnaiyan, AM,
Zgodziński, W,
Wallner, G,
Wertel, I,
Okła, K,
Kryczek, I,
Lyssiotis, CA,
Zou, W,
Nature, 2020 Sep; DOI:10.1038/s41586-020-2682-1 Breast Reconstruction Disparities in the United States and Internationally
Hart, SE,
Momoh, AO,
Current Breast Cancer Reports, 2020 Sep; DOI:10.1007/s12609-020-00366-z Primary Care Provider Involvement in Thyroid Cancer Survivorship Care
Radhakrishnan, A,
Reyes-Gastelum, D,
Gay, B,
Hawley, ST,
Hamilton, AS,
Ward, KC,
Wallner, LP,
Haymart, MR,
J Clin Endocrinol Metab, 2020 Sep; DOI:10.1210/clinem/dgaa437 Kidney cancer, version 1.2021: Featured updates to the nccn guidelines
Motzer, RJ,
Jonasch, E,
Boyle, S,
Carlo, MI,
Manley, B,
Agarwal, N,
Alva, A,
Beckermann, K,
Choueiri, TK,
Costello, BA,
Derweesh, IH,
Desai, A,
George, S,
Gore, JL,
Haas, N,
Hancock, SL,
Kyriakopoulos, C,
Lam, ET,
Lau, C,
Lewis, B,
Madoff, DC,
McCreery, B,
Michaelson, MD,
Mortazavi, A,
Nandagopal, L,
Pierorazio, PM,
Plimack, ER,
Ponsky, L,
Ramalingam, S,
Shuch, B,
Smith, ZL,
Somer, B,
Sosman, J,
Dwyer, MA,
Motter, AD,
J Natl Compr Canc Netw, 2020 Sep; DOI:10.6004/jnccn.2020.0043 Urologist Practice Structure and Quality of Prostate Cancer Care.
Modi, PK,
Yan, P,
Hollenbeck, BK,
Kaufman, SR,
Borza, T,
Skolarus, TA,
Schroeck, FR,
Ryan, AM,
Shahinian, VB,
Herrel, LA,
Urol Pract, 2020 Sep; DOI:10.1097/upj.0000000000000123 